Dobrin Consulting is a highly specialized management consulting firm focused on the Addiction with the US and on a global level. We serve pharmaceutical and health services companies. Our work is largely in the areas of product development and commercialization, portfolio strategy, new product planning and commercial strategy. The firm was started to provide services in niche areas that are often not served or not focused upon by larger consulting firms. We specialize in Addiction Markets on a global level through a team of global addiction experts by partnering with clients on issues that are difficult to resolve and that generally require deep expertise and a flexible, open, and collaborative approach that fosters creative thinking and innovation.
Our mission at Dobrin Consulting and Advisory is to make a difference while doing good for society. We are involved with the leading US and Global companies who are on the front lines of public health issues by fighting the addiction epidemics that account for such a high society burden in US and abroad! We pride ourselves in coming up with innovative solutions for such debilitating addictions as opiate dependence, alcohol dependence and cocaine dependence, among others!
Dobrin Consulting is involved in the front lines of opiate dependence epidemic:
Public health officials have called the current opioid epidemic the worst drug crisis in American history, killing more than 33,000 people in 2015. Overdose deaths were nearly equal to the number of deaths from car crashes. In 2015, for the first time, deaths from heroin alone surpassed gun homicides. (New York Times Jan 6, 2017) Heroin and oxycontin are among leading cause of crime and deaths in the US. Opiate dependence is a significant public health issues with an estimated 2.1 million people in the United States are suffering from substance use disorders related to prescription opioid pain relievers in 2012 and an estimated 467,000 addicted to heroin. (Nora Volkow, NIDA director, 2013)
Alex Lugovoy has worked within the opiate dependence market for over a decade and with Dobrin Consulting is involved with leading treatment providers and medication developers for opiate dependence. Dobrin Consulting has been the leading advisory firm to the public and private companies developing opiate dependence medications for the treatment of opiate dependence and has assisted in dozens of engagements to provide innovative solutions for the treatment of opiate dependence in US and abroad.
Dobrin Consulting is involved in the front lines of alcohol dependence epidemic:
About 12% of American adults have had an alcohol dependence problem at some time in their life.(Hasan et al 2007). Alcohol dependence is a large public health problem that may lead to broken families, abuse and loss of job, automobile accidents, as well as premature death. Alex Lugovoy and Dobrin Consulting has been working with leading alcohol dependence companies and KOLs on coming up with innovative approaches to treatment of alcohol dependence. We take pride to be on the forefront of fighting this debilitating addiction.
Dobrin Consulting is involved in the front lines of cocaine dependence epidemic:
Cocaine is the second most popular illegal recreational drug in the United States behind marijuana, “erowid.org,Oct 2007) and the U.S. is the world’s largest consumer of cocaine.(Cia.gov 2011). Its users span over different ages, ethnicities, and professions but is estimated at around 1.5 Million users in US (NSDUH, 2014). Cocaine use results in about 5,000–6,000 deaths annually. (Centers for disease control, 2012). Unlike other addictions there are currently no FDA approved treatment for cocaine dependence leaving addicted individuals with limited options for treatment. Alex Lugovoy and Dobrin Consulting have worked with leading development companies on the forefront of developing innovative treatments for cocaine dependence and we pride ourselves on being on the forefront of the battle with this serious public health issue.